Literature DB >> 16174852

Oh, Canada: Public outcry pushed demand for trastuzumab for early-stage breast cancer.

Michael Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174852     DOI: 10.1093/jnci/dji327

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

Review 1.  Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer.

Authors:  Greg L Plosker; Susan J Keam
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Media Hyping and the "Herceptin Access Story": An Analysis of Canadian and UK Newspaper Coverage.

Authors:  Julia Abelson; Patricia A Collins
Journal:  Healthc Policy       Date:  2009-02

3.  Reducing uncertainty in health-care resource allocation.

Authors:  T Simonsson; K Sjölund; P Bümming; H Ahlman; B Nilsson; A Odén
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.